Horizon Diagnostics has launched the Quantitative Multiplex DNA Reference Standard, a standard intended for researchers assessing multiple biomarkers in a single next-generation sequencing assay.
Horizon said the standard enables researchers to quantify a range of detection thresholds for 11 cancer-relevant mutations. It is currently available as genomic DNA and the company is also working on a matched formalin-fixed paraffin-embedded format to be launched later this year.